Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Processa Pharmaceuticals (PCSA)

Processa Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCSA
DateTimeSourceHeadlineSymbolCompany
22/03/202320:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
17/03/202312:30GlobeNewswire Inc.Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group with Next Generation Chemotherapy-CapecitabineNASDAQ:PCSAProcessa Pharmaceuticals Inc
07/03/202313:30GlobeNewswire Inc.Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
21/02/202313:30GlobeNewswire Inc.Processa Pharmaceuticals Announces Prioritization on Development of Next Generation ChemotherapiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
15/02/202313:30GlobeNewswire Inc.Processa Pharmaceuticals, Inc. Announces Closing of $6.25 Million Registered Direct Offering, Which Included Retail Investors and Insiders, Priced at the Market Under Nasdaq RulesNASDAQ:PCSAProcessa Pharmaceuticals Inc
13/02/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
10/02/202322:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
10/02/202322:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
10/02/202322:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
10/02/202322:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
10/02/202322:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
10/02/202313:00GlobeNewswire Inc.Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq RulesNASDAQ:PCSAProcessa Pharmaceuticals Inc
06/02/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/01/202314:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
04/01/202322:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
04/01/202322:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
04/01/202322:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
04/01/202322:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
04/01/202322:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
04/01/202322:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
04/01/202313:30GlobeNewswire Inc.Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.NASDAQ:PCSAProcessa Pharmaceuticals Inc
22/12/202219:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
14/12/202213:30GlobeNewswire Inc.Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A TrialNASDAQ:PCSAProcessa Pharmaceuticals Inc
08/11/202221:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
08/11/202221:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCSAProcessa Pharmaceuticals Inc
08/11/202221:00GlobeNewswire Inc.Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
08/11/202213:30GlobeNewswire Inc.PCS12852 Improves Gastric Emptying in Gastroparesis PatientsNASDAQ:PCSAProcessa Pharmaceuticals Inc
04/11/202215:25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
02/11/202212:30GlobeNewswire Inc.Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. ESTNASDAQ:PCSAProcessa Pharmaceuticals Inc
01/11/202212:30GlobeNewswire Inc.Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B TrialNASDAQ:PCSAProcessa Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PCSA

Your Recent History